The current stock price of EXOZ is 14.01 USD. In the past month the price decreased by -12.44%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 23.6 | 394.11B | ||
| AMGN | AMGEN INC | 14.35 | 169.00B | ||
| GILD | GILEAD SCIENCES INC | 14.57 | 148.09B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 25.17 | 110.88B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.39 | 72.79B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 814.14 | 54.85B | ||
| INSM | INSMED INC | N/A | 41.41B | ||
| NTRA | NATERA INC | N/A | 32.51B | ||
| BIIB | BIOGEN INC | 10.5 | 25.80B | ||
| UTHR | UNITED THERAPEUTICS CORP | 18.05 | 20.51B | ||
| EXAS | EXACT SCIENCES CORP | N/A | 19.21B | ||
| INCY | INCYTE CORP | 14.82 | 18.68B |
eXoZymes, Inc. is a development stage synthetic biochemical company. The company is headquartered in Monrovia California, California and currently employs 31 full-time employees. The company went IPO on 2024-11-13. The firm has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.
EXOZYMES INC
750 Royal Oaks Dr
Monrovia California CALIFORNIA US
Employees: 31
Phone: 16264151488
eXoZymes, Inc. is a development stage synthetic biochemical company. The company is headquartered in Monrovia California, California and currently employs 31 full-time employees. The company went IPO on 2024-11-13. The firm has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.
The current stock price of EXOZ is 14.01 USD. The price decreased by -0.78% in the last trading session.
EXOZ does not pay a dividend.
EXOZ has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
EXOZYMES INC (EXOZ) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.69).
EXOZYMES INC (EXOZ) will report earnings on 2026-03-31.
You can find the ownership structure of EXOZYMES INC (EXOZ) on the Ownership tab.
ChartMill assigns a technical rating of 4 / 10 to EXOZ.
ChartMill assigns a fundamental rating of 1 / 10 to EXOZ. While EXOZ seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months EXOZ reported a non-GAAP Earnings per Share(EPS) of -1.69. The EPS decreased by -256.1% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -79.66% | ||
| ROE | -106.54% | ||
| Debt/Equity | 0.01 |